ZORVOLEX

Peak

diclofenac

NDAORALCAPSULE
Approved
Oct 2013
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20

Clinical Trials (5)

NCT05026320Phase 2Completed

A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.

Started Aug 2021
76 enrolled
Soft Tissue Injury
NCT04050644Phase 4Recruiting

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

Started Oct 2018
NCT03497039Phase 1Completed

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

Started Jul 2018
47 enrolled
Pain
NCT03074162Phase 1Completed

Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers

Started Apr 2017
48 enrolled
Healthy
NCT02700815Phase 3Completed

Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain

Started May 2016
746 enrolled
Acute Pain

Loss of Exclusivity

LOE Date
Apr 23, 2030
50 months away
Patent Expiry
Apr 23, 2030

Patent Records (5)

Patent #ExpiryTypeUse Code
8679544
Apr 23, 2030
Product
8999387
Apr 23, 2030
U-55
9017721
Apr 23, 2030
Product
9173854
Apr 23, 2030
Product
9180095
Apr 23, 2030
U-55